本页面由Tiger Trade Technology Pte. Ltd.提供服务

Royalty Pharma plc

48.57
+0.08000.16%
盘后48.570.00000.00%17:42 EDT
成交量:273.04万
成交额:1.33亿
市值:283.25亿
市盈率:27.27
高:49.06
开:48.25
低:48.21
收:48.49
52周最高:49.06
52周最低:29.66
股本:5.83亿
流通股本:3.80亿
量比:0.88
换手率:0.72%
股息:0.90
股息率:1.84%
每股收益(TTM):1.78
每股收益(LYR):1.78
净资产收益率:13.20%
总资产收益率:5.15%
市净率:4.37
市盈率(LYR):27.27

数据加载中...

2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/11

重要事件披露

Form 8-K - Current report
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities